Tag: Dietary supplement law

In late 2022, supplements containing nicotinamide mononucleotide (NMN) disappeared from major retailers, including Amazon. The primary reason why NMN was off the market was a U.S. Food and Drug Administration (FDA) ruling that reclassified the substance due to its investigation as a potential pharmaceutical drug. However, as of September 2025, the FDA has formally reversed this decision, clearing the way for NMN to be marketed as a dietary supplement again.

The global dietary supplements market is booming, with a value estimated at $182 billion by 2023. However, navigating the regulatory landscape can be complex, as different countries regulate their supplements with varying degrees of oversight and unique classification systems.

Passed in 1994, the Dietary Supplement Health and Education Act (DSHEA) dramatically changed how supplements are regulated in the United States, defining them as a separate category from food and drugs. This article will explain what was the dietary Supplementation Act of 1994, detailing its key provisions, and its profound, and sometimes controversial, impact on the nutrition landscape.